Mark L. Behnke

2.2k citations

18 papers · 1.4k indexed · 1 hit paper · h-index 15

Impact in

Virology top 5%
- HIV Research and Treatment
Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods

Papers in

Virology 2
- HIV Research and Treatment 2
Pharmaceutical Science 2

Co-authors: Julian Adams Louis Plamondon Louis Grenier Janice M. Klunder Amy Cruickshank Ross L. Stein Lawrence R. Dick Shaowu Chen
Journals: Journal of Medicinal Chemistry (5 papers)Tetrahedron Letters (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)The Journal of Organic Chemistry (2 papers)
Partner nations: United States Japan Canada

In The Last Decade

Mark L. Behnke

18 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids 1998 · 543 citations

Peers

Countries citing papers authored by Mark L. Behnke

Since Specialization

Citations

This map shows the geographic impact of Mark L. Behnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Behnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Behnke more than expected).

Fields of papers citing papers by Mark L. Behnke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Behnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Behnke. The network helps show where Mark L. Behnke may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark L. Behnke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark L. Behnke Line = papers co-authored together Mark L. Behnke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy Antimicrobial Agents and Chemotherapy ·Nathan P. Wiederhold, Xin Xu, Amy Wang, Laura K. Najvar, Edward P. Garvey, Elizabeth A. Ottinger, Asaf Alimardanov, Syed Muhammad Aamir, Mark L. Behnke, William J. Hoekstra, Stephen Brand, Robert J. Schotzinger, Rosie Jaramillo, Marcos Olivo, William R. Kirkpatrick, Thomas F. Patterson	2018	20
2	The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis Antimicrobial Agents and Chemotherapy ·Nathan P. Wiederhold, Laura K. Najvar, Edward P. Garvey, Stephen Brand, Xin Xu, Elizabeth A. Ottinger, Asaf Alimardanov, Syed Muhammad Aamir, Mark L. Behnke, William J. Hoekstra, Robert J. Schotzinger, Rosie Jaramillo, Marcos Olivo, William R. Kirkpatrick, Thomas F. Patterson	2018	18
3	Synthesis and activity of quinolinylmethyl P1′ α-sulfone piperidine hydroxamate inhibitors of TACE Bioorganic & Medicinal Chemistry Letters ·Chunchun Zhang, Frank Lovering, Mark L. Behnke, Arie Zask, Vincent Sandanayaka, Linhong Sun, Yi Zhun Zhu, Weixin Xu, Yuhua Zhang, Jeremy I. Levin	2009	8
4	Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors Analytical Biochemistry ·Manjunath Ramarao, Marina W. H. Shen, Elizabeth Murphy, Weili Duan, Yajuan Zhao, John C. McKew, Katherine L. Lee, Paresh Thakker, Mark L. Behnke, James D. Clark	2008	6
5	Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2α: Optimization of in vitro potency and rat pharmacokinetics for oral efficacy Bioorganic & Medicinal Chemistry ·Katherine L. Lee, Mark L. Behnke, Megan A. Foley, Lih-Ren Chen, Weiheng Wang, D Sun, Jill Nunez, Steve Tam, Névéna Mollova, Xin Xu, Marina W. H. Shen, Manjunath Ramarao, Debra G. Goodwin, Cheryl Nickerson‐Nutter, William M. Abraham, Cara Williams, James D. Clark, John C. McKew	2007	26
6	Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α₂α Journal of Medicinal Chemistry ·Katherine L. Lee, Megan A. Foley, Lih-Ren Chen, Mark L. Behnke, Frank Lovering, Steven J. Kirincich, Weiheng Wang, Jaechul Shim, Steve Tam, Marina W. H. Shen, Aydın DEMİR, Xin Xu, Debra G. Goodwin, Manjunath Ramarao, Cheryl Nickerson‐Nutter, Trinetri Saraswati Maria Goel, K. Chen, James D. Clark, John C. McKew	2007	69
7	Inhibition of Cytosolic Phospholipase A 2 α: Hit to Lead Optimization John C. McKew, Megan A. Foley, Paresh Thakker, Mark L. Behnke, Frank Lovering, Fuk‐Wah Sum, Steve Tam, Kun Wu, Marina W. H. Shen, Wen Zhang, Mario D. González, Shanghao Liu, Anu Mahadevan, Howard Sard, Manuchi Dansa, James D. Clark	2006	10
8	Inhibition of Cytosolic Phospholipase A₂α: Hit to Lead Optimization Journal of Medicinal Chemistry ·John C. McKew, Megan A. Foley, Paresh Thakker, Mark L. Behnke, Frank Lovering, Fuk‐Wah Sum, Steve Tam, Kun Wu, Marina W. H. Shen, Wen Zhang, Mario D. González, Shanghao Liu, Anu Mahadevan, Howard Sard, Manuchi Dansa, James D. Clark	2005	63
9	ChemInform Abstract: A Novel and Efficient Synthesis of a Highly Active Analogue of clasto‐Lactacystin β‐Lactone. ChemInform ·François Soucy, Louis Grenier, Mark L. Behnke, Antonia T. Destree, Teresa A. McCormack, Julian Adams, Louis Plamondon	2000	14
10	A Novel and Efficient Synthesis of a Highly Active Analogue of clasto-Lactacystin β-Lactone Journal of the American Chemical Society ·François Soucy, Louis Grenier, Mark L. Behnke, Antonia T. Destree, Teresa A. McCormack, Julian Adams, Louis Plamondon	1999	95
11	Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids Bioorganic & Medicinal Chemistry Letters ·Julian Adams, Mark L. Behnke, Shaowu Chen, Amy Cruickshank, Lawrence R. Dick, Louis Grenier, Janice M. Klunder, А.Ф. Бурков, Louis Plamondon, Ross L. Stein Hit paper breakdown →	1998	543
12	Benzoxazolamines and Benzothiazolamines: Potent, Enantioselective Inhibitors of Leukotriene Biosynthesis with a Novel Mechanism of Action Journal of Medicinal Chemistry ·Chris Konrad, Clara K. Miao, Abby Leland Porter, Ronald Sorcek, Denice M. Spero, Damma Janti, Kollol Pal, Mark L. Behnke, Anne G. Graham	1994	24
13	A general stereocontrolled synthesis of cis-2,3 disubstituted pyrrolidines and piperidines Tetrahedron Letters ·Kollol Pal, Mark L. Behnke, Liang Tong	1993	16
14	Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones Journal of Medicinal Chemistry ·Janice M. Klunder, Karl D. Hargrave, G.D. Soepenberg, Шарапова Ирина Николаевна, Kollol Pal, Mark L. Behnke, Suresh Kapadia, Daniel W. McNeil, Joseph C. Wu, Ikechukwu Alexander Ikeoku, Julian Adams	1992	137
15	Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones Journal of Medicinal Chemistry ·Karl D. Hargrave, John Proudfoot, Karl Grozinger, George W. Cannon, 暴仁, Muchamad Rusdan, 蒋玲俐, Scott C. Mauldin, R. Ouakrat, Mark L. Behnke, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1991	183
16	A general allylation procedure using trimethylallylsilane and fluoride catalysis The Journal of Organic Chemistry ·George Majetich, Yufang Hou, David Chapman, Mark L. Behnke	1986	77
17	A stereoselective synthesis of (.+-.)-nootkatone and (.+-.)-valencene via an intramolecular Sakurai reaction The Journal of Organic Chemistry ·George Majetich, Mark L. Behnke, Ken Hull	1985	30
18	Chemoselectivity in the conjugate addition of allylsilane to Michael acceptors Tetrahedron Letters ·George Majetich, Yufang Hou, David Chapman, Mark L. Behnke	1983	29

About Mark L. Behnke

Mark L. Behnke is a scholar working on Virology, Pharmaceutical Science, Pharmacology, Physiology and Infectious Diseases, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (4 papers), Ubiquitin and proteasome pathways (3 papers), Inflammatory mediators and NSAID effects (3 papers), Chemical Synthesis and Analysis (2 papers), HIV Research and Treatment (2 papers), Antifungal resistance and susceptibility (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Virology (111 citations), Organic Chemistry (605 citations), Infectious Diseases (208 citations), Molecular Biology (749 citations) and Hematology (108 citations). Mark L. Behnke has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Julian Adams, Louis Plamondon, Louis Grenier, Janice M. Klunder, Amy Cruickshank, Ross L. Stein, Lawrence R. Dick, Shaowu Chen, George Majetich and David Chapman. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron Letters, Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact